Total Payments
$769.86
2024 Payments
$390.83
Companies
12
Transactions
43
Medicare Patients
6,762
Medicare Billing
$262,734
Payment Breakdown by Category
Food & Beverage$769.86 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $769.86 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $221.29 | 12 | $0 (2024) |
| Novo Nordisk Inc | $200.26 | 10 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $67.88 | 4 | $0 (2024) |
| Amgen Inc. | $60.58 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $46.70 | 3 | $0 (2024) |
| Exact Sciences Corporation | $36.39 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $33.82 | 2 | $0 (2024) |
| ABBVIE INC. | $32.98 | 2 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.61 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $18.71 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $390.83 | 22 | Novo Nordisk Inc ($87.27) |
| 2023 | $275.29 | 15 | Lilly USA, LLC ($111.29) |
| 2022 | $92.55 | 5 | Lilly USA, LLC ($51.36) |
| 2021 | $11.19 | 1 | Novo Nordisk Inc ($11.19) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Obesity | ||||||
| 04/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Inflammation | ||||||
| 12/07/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes | ||||||
| 10/16/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/03/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,710 | 3,063 | $177,191 | $75,641 |
| 2022 | 27 | 1,756 | 2,986 | $166,197 | $68,632 |
| 2021 | 31 | 1,731 | 2,907 | $157,811 | $68,069 |
| 2020 | 28 | 1,565 | 2,555 | $131,700 | $50,390 |
Total Patients
6,762
Total Services
11,511
Medicare Billing
$262,734
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 417 | $58,380 | $26,958 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 220 | $21,120 | $10,375 | 49.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $14,787 | $9,158 | 61.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 57 | 75 | $10,275 | $4,127 | 40.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $3,720 | $3,390 | 91.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 170 | 367 | $3,098 | $2,830 | 91.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 143 | 269 | $15,871 | $2,743 | 17.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 158 | 282 | $8,460 | $2,102 | 24.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 46 | $4,048 | $1,814 | 44.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $2,600 | $1,483 | 57.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 86 | 102 | $5,304 | $1,327 | 25.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 17 | $2,193 | $1,244 | 56.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 81 | 131 | $5,371 | $1,206 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 75 | 133 | $4,655 | $1,024 | 22.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 12 | 23 | $1,564 | $1,002 | 64.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 39 | 43 | $1,806 | $696.60 | 38.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 38 | 40 | $2,520 | $658.40 | 26.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 43 | 44 | $660.00 | $646.80 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 44 | $616.00 | $603.68 | 98.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 39 | $2,262 | $440.10 | 19.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $276.00 | $270.48 | 98.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 16 | 16 | $928.00 | $218.04 | 23.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 11 | 14 | $728.00 | $206.57 | 28.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 17 | $850.00 | $201.18 | 23.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 47 | 81 | $972.00 | $178.20 | 18.3% |
About Angela Furr, C.F.N.P
Angela Furr, C.F.N.P is a Family healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093817306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Angela Furr, C.F.N.P has received a total of $769.86 in payments from pharmaceutical and medical device companies, with $390.83 received in 2024. These payments were reported across 43 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($769.86).
As a Medicare-enrolled provider, Furr has provided services to 6,762 Medicare beneficiaries, totaling 11,511 services with total Medicare billing of $262,734. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Houston, MS
- Active Since 09/05/2006
- Last Updated 09/14/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1093817306
Products in Payments
- MOUNJARO (Drug) $202.51
- Rybelsus (Drug) $100.66
- Ozempic (Drug) $99.60
- VOQUEZNA (Drug) $67.88
- Otezla (Drug) $47.49
- Cologuard Collection Kit (Device) $36.39
- GVOKE HYPOPEN (Drug) $33.82
- VRAYLAR (Drug) $32.98
- BREZTRI (Drug) $27.91
- OFEV (Drug) $19.61
- AIRSUPRA (Drug) $18.79
- ZEPBOUND (Drug) $18.78
- TRELEGY ELLIPTA (Drug) $18.71
- Xhance (Drug) $16.67
- YUPELRI (Drug) $14.97
- Repatha (Biological) $13.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Houston
Mrs. Sarah Aguilar, N.p, N.P
Family — Payments: $167,309
Family $167,309
Margaret White, Fnp-Bc, FNP-BC
Family — Payments: $71,272
Family $71,272
Mrs. Katrina King, Arnp, ARNP
Family — Payments: $43,591
Family $43,591
Shaila Khowja, Fnp-C, FNP-C
Family — Payments: $25,332
Family $25,332
Kendrick Clack, Fnp-C, FNP-C
Family — Payments: $22,281
Family $22,281
Tammy Davis
Family — Payments: $18,660
Family $18,660